Study of XL820 Given Orally Daily to Subjects With Solid Tumors
Clinical trial NCT00350831 · COMPLETED
Trial details
- NCT number
- NCT00350831
- Sponsor
- Exelixis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.